Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Control of Effector CD8+ T Cell Function by the Transcription Factor Eomesodermin
Erika L. Pearce,1
Alan C. Mullen,1
Gislâine A. Martins,1
Connie M. Krawczyk,1
Anne S. Hutchins,1
Valerie P. Zediak,1
Monica Banica,1
Catherine B. DiCioccio,1
Darrick A. Gross,1
Chai-an Mao,4
Hao Shen,2
Nezih Cereb,5
Soo Y. Yang,5
Tullia Lindsten,1
Janet Rossant,4
Christopher A. Hunter,3
Steven L. Reiner1*
Abstract:
Activated CD8+ T cells play a critical role in host defenseagainst viruses, intracellular microbes, and tumors. It is notclear if a key regulatory transcription factor unites the effectorfunctions of CD8+ T cells. We now show that Eomesodermin (Eomes),a paralogue of T-bet, is induced in effector CD8+ T cells invitro and in vivo. Ectopic expression of Eomes was sufficientto invoke attributes of effector CD8+ T cells, including interferon-(IFN-), perforin, and granzyme B. Loss-of-function analysissuggests Eomes may also be necessary for full effector differentiationof CD8+ T cells. We suggest that Eomesodermin is likely to complementthe actions of T-bet and act as a key regulatory gene in thedevelopment of cell-mediated immunity.
1 Abramson Family Cancer Research Institute, and Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. 2 Department of Microbiology, University of Pennsylvania, Philadelphia, PA 19104, USA. 3 Department of Pathobiology, University of Pennsylvania, Philadelphia, PA 19104, USA. 4 Samuel Lunenfeld Research Institute, and Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada M5G 1X5. 5 Histogenetics, and Center for Genetic Polymorphism, Ossining, NY 10562, USA.
* To whom correspondence should be addressed. E-mail: sreiner{at}mail.med.upenn.edu
The editors suggest the following Related Resources on Science sites:
T Cell-Specific Notch Inhibition Blocks Graft-versus-Host Disease by Inducing a Hyporesponsive Program in Alloreactive CD4+ and CD8+ T Cells.
A. R. Sandy, J. Chung, T. Toubai, G. T. Shan, I. T. Tran, A. Friedman, T. S. Blackwell, P. Reddy, P. D. King, and I. Maillard (2013)
J. Immunol.
190, 5818-5828
|Abstract »|Full Text »|PDF »
Stepwise Epigenetic and Phenotypic Alterations Poise CD8+ T Cells To Mediate Airway Hyperresponsiveness and Inflammation.
Y. Jia, K. Takeda, J. Han, A. Joetham, R. A. Marcus, J. J. Lucas, B. P. O'Connor, and E. W. Gelfand (2013)
J. Immunol.
190, 4056-4065
|Abstract »|Full Text »|PDF »
IL-21 Promotes CD8+ CTL Activity via the Transcription Factor T-bet.
A. P. R. Sutherland, N. Joller, M. Michaud, S. M. Liu, V. K. Kuchroo, and M. J. Grusby (2013)
J. Immunol.
190, 3977-3984
|Abstract »|Full Text »|PDF »
Differential Localization of T-bet and Eomes in CD8 T Cell Memory Populations.
L. M. McLane, P. P. Banerjee, G. L. Cosma, G. Makedonas, E. J. Wherry, J. S. Orange, and M. R. Betts (2013)
J. Immunol.
190, 3207-3215
|Abstract »|Full Text »|PDF »
Disparate Roles for STAT5 in Primary and Secondary CTL Responses.
CD8{alpha}+ Dendritic Cell Trans Presentation of IL-15 to Naive CD8+ T Cells Produces Antigen-Inexperienced T Cells in the Periphery with Memory Phenotype and Function.
T. Sosinowski, J. T. White, E. W. Cross, C. Haluszczak, P. Marrack, L. Gapin, and R. M. Kedl (2013)
J. Immunol.
190, 1936-1947
|Abstract »|Full Text »|PDF »
Technical Advance: Fluorescent reporter reveals insights into eomesodermin biology in cytotoxic lymphocytes.
M. A. Paley, S. M. Gordon, E. K. Bikoff, E. J. Robertson, E. J. Wherry, and S. L. Reiner (2013)
J. Leukoc. Biol.
93, 307-315
|Abstract »|Full Text »|PDF »
SLAT Regulates CD8+ T Cell Clonal Expansion in a Cdc42- and NFAT1-Dependent Manner.
S. Feau, S. P. Schoenberger, A. Altman, and S. Becart (2013)
J. Immunol.
190, 174-183
|Abstract »|Full Text »|PDF »
Contribution of Pulmonary KLRG1high and KLRG1low CD8 T Cells to Effector and Memory Responses during Influenza Virus Infection.
Conditional deletion of cytokine receptor chains reveals that IL-7 and IL-15 specify CD8 cytotoxic lineage fate in the thymus.
T. M. McCaughtry, R. Etzensperger, A. Alag, X. Tai, S. Kurtulus, J.-H. Park, A. Grinberg, P. Love, L. Feigenbaum, B. Erman, et al. (2012)
J. Exp. Med.
209, 2263-2276
|Abstract »|Full Text »|PDF »
Induction of tumoricidal function in CD4+ T cells is associated with concomitant memory and terminally differentiated phenotype.
D. Hirschhorn-Cymerman, S. Budhu, S. Kitano, C. Liu, F. Zhao, H. Zhong, A. M. Lesokhin, F. Avogadri-Connors, J. Yuan, Y. Li, et al. (2012)
J. Exp. Med.
209, 2113-2126
|Abstract »|Full Text »|PDF »
Endogenous antigen presentation impacts on T-box transcription factor expression and functional maturation of CD8+ T cells.
C. Smith, D. Elhassen, S. Gras, K. K. Wynn, V. Dasari, J. Tellam, S.-K. Tey, S. Rehan, Y. C. Liu, J. Rossjohn, et al. (2012)
Blood
120, 3237-3245
|Abstract »|Full Text »|PDF »
TCR signaling via Tec kinase ITK and interferon regulatory factor 4 (IRF4) regulates CD8+ T-cell differentiation.
R. Nayar, M. Enos, A. Prince, H. Shin, S. Hemmers, J.-k. Jiang, U. Klein, C. J. Thomas, and L. J. Berg (2012)
PNAS
109, E2794-E2802
|Abstract »|Full Text »|PDF »
The Molecular Signature of Tissue Resident Memory CD8 T Cells Isolated from the Brain.
L. M. Wakim, A. Woodward-Davis, R. Liu, Y. Hu, J. Villadangos, G. Smyth, and M. J. Bevan (2012)
J. Immunol.
189, 3462-3471
|Abstract »|Full Text »|PDF »
Abrogation of Src Homology Region 2 Domain-Containing Phosphatase 1 in Tumor-Specific T Cells Improves Efficacy of Adoptive Immunotherapy by Enhancing the Effector Function and Accumulation of Short-Lived Effector T Cells In Vivo.
I. M. Stromnes, C. Fowler, C. C. Casamina, C. M. Georgopolos, M. S. McAfee, T. M. Schmitt, X. Tan, T.-D. Kim, I. Choi, J. N. Blattman, et al. (2012)
J. Immunol.
189, 1812-1825
|Abstract »|Full Text »|PDF »
Activation of the Hippo pathway by CTLA-4 regulates the expression of Blimp-1 in the CD8+ T cell.
J. E. D. Thaventhiran, A. Hoffmann, L. Magiera, M. de la Roche, H. Lingel, M. Brunner-Weinzierl, and D. T. Fearon (2012)
PNAS
109, E2223-E2229
|Abstract »|Full Text »|PDF »
Interferon regulatory factor 8 integrates T-cell receptor and cytokine-signaling pathways and drives effector differentiation of CD8 T cells.
F. Miyagawa, H. Zhang, A. Terunuma, K. Ozato, Y. Tagaya, and S. I. Katz (2012)
PNAS
109, 12123-12128
|Abstract »|Full Text »|PDF »
Autocrine IFN-{gamma} Promotes Naive CD8 T Cell Differentiation and Synergizes with IFN-{alpha} To Stimulate Strong Function.
J. M. Curtsinger, P. Agarwal, D. C. Lins, and M. F. Mescher (2012)
J. Immunol.
189, 659-668
|Abstract »|Full Text »|PDF »
Breakdown in Repression of IFN-{gamma} mRNA Leads to Accumulation of Self-Reactive Effector CD8+ T Cells.
P.-P. Chang, S. K. Lee, X. Hu, G. Davey, G. Duan, J.-H. Cho, G. Karupiah, J. Sprent, W. R. Heath, E. M. Bertram, et al. (2012)
J. Immunol.
189, 701-710
|Abstract »|Full Text »|PDF »
Notch system in the linkage of innate and adaptive immunity.
T. Ito, J. M. Connett, S. L. Kunkel, and A. Matsukawa (2012)
J. Leukoc. Biol.
92, 59-65
|Abstract »|Full Text »|PDF »
Multifunctional CD4 Cells Expressing Gamma Interferon and Perforin Mediate Protection against Lethal Influenza Virus Infection.
D. M. Brown, S. Lee, M. d. l. L. Garcia-Hernandez, and S. L. Swain (2012)
J. Virol.
86, 6792-6803
|Abstract »|Full Text »|PDF »
Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells.
S. Gill, A. E. Vasey, A. De Souza, J. Baker, A. T. Smith, H. E. Kohrt, M. Florek, K. D. Gibbs Jr, K. Tate, D. S. Ritchie, et al. (2012)
Blood
119, 5758-5768
|Abstract »|Full Text »|PDF »
Chronic HIV infection affects the expression of the 2 transcription factors required for CD8 T-cell differentiation into cytolytic effectors.
P. Ribeiro-dos-Santos, E. L. Turnbull, M. Monteiro, A. Legrand, K. Conrod, J. Baalwa, P. Pellegrino, G. M. Shaw, I. Williams, P. Borrow, et al. (2012)
Blood
119, 4928-4938
|Abstract »|Full Text »|PDF »
Identification of a New Pathway for Th1 Cell Development Induced by Cooperative Stimulation with IL-4 and TGF-{beta}.
S. Tofukuji, M. Kuwahara, J. Suzuki, O. Ohara, T. Nakayama, and M. Yamashita (2012)
J. Immunol.
188, 4846-4857
|Abstract »|Full Text »|PDF »
CD8 T Cells Recruited Early in Mouse Polyomavirus Infection Undergo Exhaustion.
J. J. Wilson, C. D. Pack, E. Lin, E. L. Frost, J. A. Albrecht, A. Hadley, A. R. Hofstetter, S. S. Tevethia, T. D. Schell, and A. E. Lukacher (2012)
J. Immunol.
188, 4340-4348
|Abstract »|Full Text »|PDF »
T Cell Factor-1 and {beta}-Catenin Control the Development of Memory-like CD8 Thymocytes.
A. Sharma, Q. Chen, T. Nguyen, Q. Yu, and J. Misra Sen (2012)
J. Immunol.
188, 3859-3868
|Abstract »|Full Text »|PDF »
Glycodelin-A interferes with IL-2/IL-2R signalling to induce cell growth arrest, loss of effector functions and apoptosis in T-lymphocytes.
Inhibition of histone methylation arrests ongoing graft-versus-host disease in mice by selectively inducing apoptosis of alloreactive effector T cells.
S. He, J. Wang, K. Kato, F. Xie, S. Varambally, S. Mineishi, R. Kuick, K. Mochizuki, Y. Liu, E. Nieves, et al. (2012)
Blood
119, 1274-1282
|Abstract »|Full Text »|PDF »
IL-12 selectively programs effector pathways that are stably expressed in human CD8+ effector memory T cells in vivo.
F. Z. Chowdhury, H. J. Ramos, L. S. Davis, J. Forman, and J. D. Farrar (2011)
Blood
118, 3890-3900
|Abstract »|Full Text »|PDF »
CD134 Plus CD137 Dual Costimulation Induces Eomesodermin in CD4 T Cells To Program Cytotoxic Th1 Differentiation.
H. Z. Qui, A. T. Hagymasi, S. Bandyopadhyay, M.-C. St. Rose, R. Ramanarasimhaiah, A. Menoret, R. S. Mittler, S. M. Gordon, S. L. Reiner, A. T. Vella, et al. (2011)
J. Immunol.
187, 3555-3564
|Abstract »|Full Text »|PDF »
The 'T-cell-ness' of NK cells: unexpected similarities between NK cells and T cells.
E. Narni-Mancinelli, E. Vivier, and Y. M. Kerdiles (2011)
Int. Immunol.
23, 427-431
|Abstract »|Full Text »|PDF »
Novel TGF-{beta} Antagonist Inhibits Tumor Growth and Angiogenesis by Inducing IL-2 Receptor-Driven STAT1 Activation.
C. Penafuerte, N. Bautista-Lopez, M. Bouchentouf, E. Birman, K. Forner, and J. Galipeau (2011)
J. Immunol.
186, 6933-6944
|Abstract »|Full Text »|PDF »
Stat4 Is Critical for the Balance between Th17 Cells and Regulatory T Cells in Colitis.
J. Xu, Y. Yang, G. Qiu, G. Lal, N. Yin, Z. Wu, J. S. Bromberg, and Y. Ding (2011)
J. Immunol.
186, 6597-6606
|Abstract »|Full Text »|PDF »
Control of Toxoplasma reactivation by rescue of dysfunctional CD8+ T-cell response via PD-1-PDL-1 blockade.
R. Bhadra, J. P. Gigley, L. M. Weiss, and I. A. Khan (2011)
PNAS
108, 9196-9201
|Abstract »|Full Text »|PDF »
Reprogramming CD19-Specific T Cells with IL-21 Signaling Can Improve Adoptive Immunotherapy of B-Lineage Malignancies.
H. Singh, M. J. Figliola, M. J. Dawson, H. Huls, S. Olivares, K. Switzer, T. Mi, S. Maiti, P. Kebriaei, D. A. Lee, et al. (2011)
Cancer Res.
71, 3516-3527
|Abstract »|Full Text »|PDF »
MHC Class II-Restricted Interaction between Thymocytes Plays an Essential Role in the Production of Innate CD8+ T Cells.
H. S. Min, Y. J. Lee, Y. K. Jeon, E. J. Kim, B. H. Kang, K. C. Jung, C.-H. Chang, and S. H. Park (2011)
J. Immunol.
186, 5749-5757
|Abstract »|Full Text »|PDF »
Requirements for Eomesodermin and Promyelocytic Leukemia Zinc Finger in the Development of Innate-Like CD8+ T Cells.
S. M. Gordon, S. A. Carty, J. S. Kim, T. Zou, J. Smith-Garvin, E. S. Alonzo, E. Haimm, D. B. Sant'Angelo, G. A. Koretzky, S. L. Reiner, et al. (2011)
J. Immunol.
186, 4573-4578
|Abstract »|Full Text »|PDF »
Increased HIV-specific CD8+ T-cell cytotoxic potential in HIV elite controllers is associated with T-bet expression.
A. R. Hersperger, J. N. Martin, L. Y. Shin, P. M. Sheth, C. M. Kovacs, G. L. Cosma, G. Makedonas, F. Pereyra, B. D. Walker, R. Kaul, et al. (2011)
Blood
117, 3799-3808
|Abstract »|Full Text »|PDF »
Human effector CD8+ T cells derived from naive rather than memory subsets possess superior traits for adoptive immunotherapy.
C. S. Hinrichs, Z. A. Borman, L. Gattinoni, Z. Yu, W. R. Burns, J. Huang, C. A. Klebanoff, L. A. Johnson, S. P. Kerkar, S. Yang, et al. (2011)
Blood
117, 808-814
|Abstract »|Full Text »|PDF »
Cutting Edge: Lymphoproliferation Caused by Fas Deficiency Is Dependent on the Transcription Factor Eomesodermin.
I. Kinjyo, S. M. Gordon, A. M. Intlekofer, K. Dowdell, E. C. Mooney, R. Caricchio, S. A. Grupp, D. T. Teachey, V. K. Rao, T. Lindsten, et al. (2010)
J. Immunol.
185, 7151-7155
|Abstract »|Full Text »|PDF »
Modulation of human neutrophil survival and antigen expression by activated CD4+ and CD8+ T cells.
M. Pelletier, A. Micheletti, and M. A. Cassatella (2010)
J. Leukoc. Biol.
88, 1163-1170
|Abstract »|Full Text »|PDF »
Cutting Edge: The Transcription Factor Eomesodermin Enables CD8+ T Cells To Compete for the Memory Cell Niche.
A. Banerjee, S. M. Gordon, A. M. Intlekofer, M. A. Paley, E. C. Mooney, T. Lindsten, E. J. Wherry, and S. L. Reiner (2010)
J. Immunol.
185, 4988-4992
|Abstract »|Full Text »|PDF »
T-bet and Eomesodermin Are Required for T Cell-Mediated Antitumor Immune Responses.
Y. Zhu, S. Ju, E. Chen, S. Dai, C. Li, P. Morel, L. Liu, X. Zhang, and B. Lu (2010)
J. Immunol.
185, 3174-3183
|Abstract »|Full Text »|PDF »
Defective feedback regulation of NF-{kappa}B underlies Sjogren's syndrome in mice with mutated {kappa}B enhancers of the I{kappa}B{alpha} promoter.
B. Peng, J. Ling, A. J. Lee, Z. Wang, Z. Chang, W. Jin, Y. Kang, R. Zhang, D. Shim, H. Wang, et al. (2010)
PNAS
107, 15193-15198
|Abstract »|Full Text »|PDF »
Tc17 Cells Are Capable of Mediating Immunity to Vaccinia Virus by Acquisition of a Cytotoxic Phenotype.
N. Yeh, N. L. Glosson, N. Wang, L. Guindon, C. McKinley, H. Hamada, Q. Li, R. W. Dutton, P. Shrikant, B. Zhou, et al. (2010)
J. Immunol.
185, 2089-2098
|Abstract »|Full Text »|PDF »
Antigen-specific clonal expansion and cytolytic effector function of CD8+ T lymphocytes depend on the transcription factor Bcl11b.
S. Zhang, M. Rozell, R. K. Verma, D. I. Albu, D. Califano, J. VanValkenburgh, A. Merchant, J. Rangel-Moreno, T. D. Randall, N. A. Jenkins, et al. (2010)
J. Exp. Med.
207, 1687-1699
|Abstract »|Full Text »|PDF »
Distal Regions of the Human IFNG Locus Direct Cell Type-Specific Expression.
P. L. Collins, S. Chang, M. Henderson, M. Soutto, G. M. Davis, A. G. McLoed, M. J. Townsend, L. H. Glimcher, D. P. Mortlock, and T. M. Aune (2010)
J. Immunol.
185, 1492-1501
|Abstract »|Full Text »|PDF »
IFN-{alpha}{beta} and Self-MHC Divert CD8 T Cells into a Distinct Differentiation Pathway Characterized by Rapid Acquisition of Effector Functions.
H. D. Marshall, A. L. Prince, L. J. Berg, and R. M. Welsh (2010)
J. Immunol.
185, 1419-1428
|Abstract »|Full Text »|PDF »
Smad2 and Smad3 Are Redundantly Essential for the TGF-{beta}-Mediated Regulation of Regulatory T Plasticity and Th1 Development.
T. Takimoto, Y. Wakabayashi, T. Sekiya, N. Inoue, R. Morita, K. Ichiyama, R. Takahashi, M. Asakawa, G. Muto, T. Mori, et al. (2010)
J. Immunol.
185, 842-855
|Abstract »|Full Text »|PDF »
Naturally Activated V{gamma}4 {gamma}{delta} T Cells Play a Protective Role in Tumor Immunity through Expression of Eomesodermin.
W. He, J. Hao, S. Dong, Y. Gao, J. Tao, H. Chi, R. Flavell, R. L. O'Brien, W. K. Born, J. Craft, et al. (2010)
J. Immunol.
185, 126-133
|Abstract »|Full Text »|PDF »
Distinct Roles for IL-2 and IL-15 in the Differentiation and Survival of CD8+ Effector and Memory T Cells.
D. M. Mitchell, E. V. Ravkov, and M. A. Williams (2010)
J. Immunol.
184, 6719-6730
|Abstract »|Full Text »|PDF »
{gamma}c deficiency precludes CD8+ T cell memory despite formation of potent T cell effectors.
H. Decaluwe, M. Taillardet, E. Corcuff, I. Munitic, H. K. W. Law, B. Rocha, Y. Riviere, and J. P. Di Santo (2010)
PNAS
107, 9311-9316
|Abstract »|Full Text »|PDF »
Pharmacologic Induction of CD8+ T Cell Memory: Better Living Through Chemistry.
L. Gattinoni, C. A. Klebanoff, and N. P. Restifo (2009)
Science Translational Medicine
1, 11ps12
|Full Text »|PDF »
Interplay between Chromatin Remodeling and Epigenetic Changes during Lineage-Specific Commitment to Granzyme B Expression.
T. Juelich, E. Sutcliffe, A. Denton, Y. He, P. C. Doherty, C. Parish, S. J. Turner, D. Tremethick, and S. Rao (2009)
J. Immunol.
183, 7063-7072
|Abstract »|Full Text »|PDF »
Kinetics of the Immune Response Profile in Guinea Pigs after Vaccination with Mycobacterium bovis BCG and Infection with Mycobacterium tuberculosis.
A. Grover, J. Taylor, J. Troudt, A. Keyser, K. Arnett, L. Izzo, D. Rholl, and A. Izzo (2009)
Infect. Immun.
77, 4837-4846
|Abstract »|Full Text »|PDF »
Functionally Mature CD4 and CD8 TCR{alpha}{beta} Cells Are Generated in OP9-DL1 Cultures from Human CD34+ Hematopoietic Cells.
S. Van Coppernolle, G. Verstichel, F. Timmermans, I. Velghe, D. Vermijlen, M. De Smedt, G. Leclercq, J. Plum, T. Taghon, B. Vandekerckhove, et al. (2009)
J. Immunol.
183, 4859-4870
|Abstract »|Full Text »|PDF »
ThPOK Derepression Is Required for Robust CD8 T cell Responses to Viral Infection.
R. Setoguchi, I. Taniuchi, and M. J. Bevan (2009)
J. Immunol.
183, 4467-4474
|Abstract »|Full Text »|PDF »
CXCR3 Deficiency Increases Susceptibility to Genital Herpes Simplex Virus Type 2 Infection: Uncoupling of CD8+ T-Cell Effector Function but Not Migration.
Gene Regulation and Chromatin Remodeling by IL-12 and Type I IFN in Programming for CD8 T Cell Effector Function and Memory.
P. Agarwal, A. Raghavan, S. L. Nandiwada, J. M. Curtsinger, P. R. Bohjanen, D. L. Mueller, and M. F. Mescher (2009)
J. Immunol.
183, 1695-1704
|Abstract »|Full Text »|PDF »
Type 17 CD8+ T cells display enhanced antitumor immunity.
C. S. Hinrichs, A. Kaiser, C. M. Paulos, L. Cassard, L. Sanchez-Perez, B. Heemskerk, C. Wrzesinski, Z. A. Borman, P. Muranski, and N. P. Restifo (2009)
Blood
114, 596-599
|Abstract »|Full Text »|PDF »
Histone Acetyltransferase CBP Is Vital To Demarcate Conventional and Innate CD8+ T-Cell Development.
T. Fukuyama, L. H. Kasper, F. Boussouar, T. Jeevan, J. van Deursen, and P. K. Brindle (2009)
Mol. Cell. Biol.
29, 3894-3904
|Abstract »|Full Text »|PDF »
IL-23 Promotes the Production of IL-17 by Antigen-Specific CD8 T Cells in the Absence of IL-12 and Type-I Interferons.
T-bet-Deficient NOD Mice Are Protected from Diabetes Due to Defects in Both T Cell and Innate Immune System Function.
J. H. Esensten, M. R. Lee, L. H. Glimcher, and J. A. Bluestone (2009)
J. Immunol.
183, 75-82
|Abstract »|Full Text »|PDF »
Requirement for AHNAK1-mediated calcium signaling during T lymphocyte cytolysis.
D. Matza, A. Badou, M. K. Jha, T. Willinger, A. Antov, S. Sanjabi, K. S. Kobayashi, V. T. Marchesi, and R. A. Flavell (2009)
PNAS
106, 9785-9790
|Abstract »|Full Text »|PDF »
T-bet Inhibits the In Vivo Differentiation of Parasite-Specific CD4+ Th17 Cells in a T Cell-Intrinsic Manner.
Many different V{beta} CDR3s can reveal the inherent MHC reactivity of germline-encoded TCR V regions.
K. Rubtsova, J. P. Scott-Browne, F. Crawford, S. Dai, P. Marrack, and J. W. Kappler (2009)
PNAS
106, 7951-7956
|Abstract »|Full Text »|PDF »
The molecular signature of CD8+ T cells undergoing deletional tolerance.
I. A. Parish, S. Rao, G. K. Smyth, T. Juelich, G. S. Denyer, G. M. Davey, A. Strasser, and W. R. Heath (2009)
Blood
113, 4575-4585
|Abstract »|Full Text »|PDF »
IL-23 Drives Pathogenic IL-17-Producing CD8+ T Cells.
B. Ciric, M. El-behi, R. Cabrera, G.-X. Zhang, and A. Rostami (2009)
J. Immunol.
182, 5296-5305
|Abstract »|Full Text »|PDF »
Impaired CD4 and CD8 Effector Function and Decreased Memory T Cell Populations in ICOS-Deficient Patients.
N. Takahashi, K. Matsumoto, H. Saito, T. Nanki, N. Miyasaka, T. Kobata, M. Azuma, S.-K. Lee, S. Mizutani, and T. Morio (2009)
J. Immunol.
182, 5515-5527
|Abstract »|Full Text »|PDF »
Notch Regulates Cytolytic Effector Function in CD8+ T Cells.
O. H. Cho, H. M. Shin, L. Miele, T. E. Golde, A. Fauq, L. M. Minter, and B. A. Osborne (2009)
J. Immunol.
182, 3380-3389
|Abstract »|Full Text »|PDF »
IL-21-Mediated Potentiation of Antitumor Cytolytic and Proinflammatory Responses of Human V{gamma}9V{delta}2 T Cells for Adoptive Immunotherapy.
A. Thedrez, C. Harly, A. Morice, S. Salot, M. Bonneville, and E. Scotet (2009)
J. Immunol.
182, 3423-3431
|Abstract »|Full Text »|PDF »
Eomesodermin Requires Transforming Growth Factor-{beta}/Activin Signaling and Binds Smad2 to Activate Mesodermal Genes.
P. Picozzi, F. Wang, K. Cronk, and K. Ryan (2009)
J. Biol. Chem.
284, 2397-2408
|Abstract »|Full Text »|PDF »
Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs.
F. Cruz-Guilloty, M. E. Pipkin, I. M. Djuretic, D. Levanon, J. Lotem, M. G. Lichtenheld, Y. Groner, and A. Rao (2009)
J. Exp. Med.
206, 51-59
|Abstract »|Full Text »|PDF »
The cytolytic enzymes granyzme A, granzyme B, and perforin: expression patterns, cell distribution, and their relationship to cell maturity and bright CD57 expression.
P. K. Chattopadhyay, M. R. Betts, D. A. Price, E. Gostick, H. Horton, M. Roederer, and S. C. De Rosa (2009)
J. Leukoc. Biol.
85, 88-97
|Abstract »|Full Text »|PDF »
T-bet and Eomesodermin Play Critical Roles in Directing T Cell Differentiation to Th1 versus Th17.
Y. Yang, J. Xu, Y. Niu, J. S. Bromberg, and Y. Ding (2008)
J. Immunol.
181, 8700-8710
|Abstract »|Full Text »|PDF »
Self-Antigen Prevents CD8 T Cell Effector Differentiation by CD134 and CD137 Dual Costimulation.
S. Bandyopadhyay, M. Long, H. Z. Qui, A. T. Hagymasi, A. M. Slaiby, M. A. Mihalyo, H. L. Aguila, R. S. Mittler, A. T. Vella, and A. J. Adler (2008)
J. Immunol.
181, 7728-7737
|Abstract »|Full Text »|PDF »
CD8+ Th17 Mediate Costimulation Blockade-Resistant Allograft Rejection in T-bet-Deficient Mice.
B. E. Burrell, K. Csencsits, G. Lu, S. Grabauskiene, and D. K. Bishop (2008)
J. Immunol.
181, 3906-3914
|Abstract »|Full Text »|PDF »
Selective miRNA disruption in T reg cells leads to uncontrolled autoimmunity.
X. Zhou, L. T. Jeker, B. T. Fife, S. Zhu, M. S. Anderson, M. T. McManus, and J. A. Bluestone (2008)
J. Exp. Med.
205, 1983-1991
|Abstract »|Full Text »|PDF »
Phenotype and Functional Characterization of Long-term gp100-Specific Memory CD8+ T Cells in Disease-Free Melanoma Patients Before and After Boosting Immunization.
E. B. Walker, D. Haley, U. Petrausch, K. Floyd, W. Miller, N. Sanjuan, G. Alvord, B. A. Fox, and W. J. Urba (2008)
Clin. Cancer Res.
14, 5270-5283
|Abstract »|Full Text »|PDF »
Identification of an Evolutionarily Conserved Transcriptional Signature of CD8 Memory Differentiation That Is Shared by T and B Cells.
W. N. Haining, B. L. Ebert, A. Subrmanian, E. J. Wherry, Q. Eichbaum, J. W. Evans, R. Mak, S. Rivoli, J. Pretz, J. Angelosanto, et al. (2008)
J. Immunol.
181, 1859-1868
|Abstract »|Full Text »|PDF »
Anomalous Type 17 Response to Viral Infection by CD8+ T Cells Lacking T-bet and Eomesodermin.
A. M. Intlekofer, A. Banerjee, N. Takemoto, S. M. Gordon, C. S. DeJong, H. Shin, C. A. Hunter, E. J. Wherry, T. Lindsten, and S. L. Reiner (2008)
Science
321, 408-411
|Abstract »|Full Text »|PDF »
T-Bet Plays a Key Role in NK-Mediated Control of Melanoma Metastatic Disease.
M. B. F. Werneck, G. Lugo-Villarino, E. S. Hwang, H. Cantor, and L. H. Glimcher (2008)
J. Immunol.
180, 8004-8010
|Abstract »|Full Text »|PDF »
Histone Acetylation Facilitates Rapid and Robust Memory CD8 T Cell Response through Differential Expression of Effector Molecules (Eomesodermin and Its Targets: Perforin and Granzyme B).
Y. Araki, M. Fann, R. Wersto, and N.-p. Weng (2008)
J. Immunol.
180, 8102-8108
|Abstract »|Full Text »|PDF »
IL-2 and IL-21 confer opposing differentiation programs to CD8+ T cells for adoptive immunotherapy.
C. S. Hinrichs, R. Spolski, C. M. Paulos, L. Gattinoni, K. W. Kerstann, D. C. Palmer, C. A. Klebanoff, S. A. Rosenberg, W. J. Leonard, and N. P. Restifo (2008)
Blood
111, 5326-5333
|Abstract »|Full Text »|PDF »
Effector CD8 T Cell Development: A Balancing Act between Memory Cell Potential and Terminal Differentiation.